Engineered TrpB Subunits for Independent Non-Canonical Amino Acid Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing non-canonical amino acids using tryptophan synthase are limited by low substrate concentrations, low yields, and poor thermostability, with the isolated β-subunit (TrpB) losing significant activity and being difficult to utilize independently due to allosteric regulation by the α-subunit.

Innovation Solution

Engineering recombinant β-subunits of tryptophan synthase with specific mutations, such as T292S and others, allowing them to catalyze the production of non-canonical amino acids independently of the α-subunit, with improved catalytic efficiency and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If the isolated β-subunit (TrpB) is used for producing non-canonical amino acids, then the metabolic load on host cells is reduced and engineering becomes easier, but the catalytic activity is significantly lost due to allosteric regulation by the α-subunit

Engineering Contradiction:
Improvecomplexity of enzyme systemVSAvoidcatalytic activity
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The invention extracts the β-subunit (TrpB) from the heterodimeric tryptophan synthase complex to create an isolated enzyme system. This extraction enables independent expression and engineering of TrpB without requiring the α-subunit, thereby reducing metabolic load and simplifying the system while maintaining catalytic function through directed evolution

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention applies parameter changes through directed evolution to modify the β-subunit's properties. Specific mutations (e.g., F10L, L12L, E17G, V68V, F274S, T292S, T321A) are introduced to alter the enzyme's allosteric regulation characteristics, enabling it to function independently with restored and optimized catalytic activity

Inventive Principle:
Principle #35Parameter changes

2Reliability

If the heterodimeric tryptophan synthase complex is used, then catalytic activity is maintained through allosteric regulation, but the metabolic load on host cells increases and engineering of activity and substrate specificity becomes more difficult

Engineering Contradiction:
Improvecatalytic activityVSAvoidcomplexity of enzyme system
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention extracts the β-subunit (TrpB) from the heterodimeric tryptophan synthase complex to create an isolated enzyme system. This extraction enables independent expression and engineering of TrpB without requiring the α-subunit, thereby reducing metabolic load and simplifying the system while maintaining catalytic function through directed evolution

Inventive Principle:
Principle #2Taking out (Extraction)

3Adaptability or versatility

If wild-type tryptophan synthase is used for non-canonical amino acid production, then the enzyme maintains natural substrate specificity, but the yields are low and thermostability is poor

Engineering Contradiction:
Improvesubstrate specificityVSAvoidyield and thermostability
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The invention applies parameter changes through directed evolution to modify the β-subunit's properties. Specific mutations (e.g., F10L, L12L, E17G, V68V, F274S, T292S, T321A) are introduced to alter the enzyme's allosteric regulation characteristics, enabling it to function independently with restored and optimized catalytic activity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered TrpB subunits demonstrate enhanced catalytic activity and stability, enabling efficient production of non-canonical amino acids at higher yields and temperatures, suitable for applications in chemical biology and pharmaceuticals.

Implementation Method 1

The engineered TrpB subunits demonstrate enhanced catalytic activity and stability, enabling efficient production of non-canonical amino acids

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Data Source

PatentUS12534748B2Engineered beta-subunit of tryptophan synthase for production of non-canonical amino acids
Publication Date: 2026.01.27 CALIFORNIA INST OF TECH
  • US12534748B2 patent drawing
  • US12534748B2 patent drawing
  • US12534748B2 patent drawing

AI summary

This disclosure relates to modified tryptophan synthase and more particularly to modified beta-subunits of tryptophan synthase. The disclosure further relates to cells expressing such modified subunits and methods of producing non-canonical amino acids.